iimena

Integrating Informatics and Metabolic Engineering for the biosynthesis of Novel Antibiotics

Welcome to the homepage of the iimena project consortium

 

The iimena-project aims to integrate state-of-the art screening technologies, bioinformatics and metabolic engineering approches in order to identify and characterize novel secondary metabolites from actinomycetes, which can become lead-candidates for antibiotic drug development.

The iimena-project is funded by a Challenge Grant of the:

<b>iimena</b><br/><br/>Integrating Informatics and Metabolic Engineering for the biosynthesis of Novel Antibiotics

The iimena project

ABOUT
JOBS
CONTACT

News

Postdoctoral position in Streptomyces Strain Design at the Novo Nordisk Foundation Center for Biosustainability (DTU Biosustain), Technical University of Denmark
October 26, 2020
Are you a highly motivated postdoctoral researcher with an interest in CRISPR applications in microorganisms, and experience in molecular biology with actinomycetes, and would like to join o...
Finding new antibiotics: The genome way
Finding new antibiotics: The genome way
August 28, 2020
The iimena project funded by a Challenge Grant by the Novo Nordisk Foundation integrates BGC discovery with innovative high throughput screening, adaptive laboratory evolution and metabolic ...
Streptomyces CRISPR Protocols published in Nature Protocols
July 12, 2020
An important aim of the iimena project is to develop methods that enable us to more efficiently get access to the potential new antibiotics produced by actinomycetes. One of the most imp...